European Regulatory Roundup: Medtech Industry Pressures Brexit Negotiators to Maintain UK-EU Relationship (21 September 2017)
By Nick Paul Taylor -
Published 21 September 2017
Welcome to our European Regulatory Roundup, our weekly overview of the top EU regulatory news.
Categories: News, Europe, EMA, MHRA, Biologics and biotechnology, Medical Devices, Regulatory intelligence, Regulatory strategy
Tags: European Regulatory Roundup, Brexit, biosimilar switching, vaccines
EU Industry Groups Urge Caution on Biosimilar Switching
By Zachary Brennan -
Published 09 March 2017
Three EU biopharmaceutical industry groups are offering key considerations to physicians when switching from a biologic reference product to its biosimilar or from one biosimilar of a reference product to another, according to a new position paper released on Thursday.
Categories: Europe, EC, EMA, Biologics and biotechnology, Compliance, Regulatory intelligence, Regulatory strategy
Tags: biosimilars, biosimilar switching, regulatory requirements biosimilars